In partnership with the UW Collaborative Genomics Core and the UW Carbone Cancer Center (UWCCC), the Precision Medicine Molecular Tumor Board (PMMTB) is a statewide service available to oncologists at UW Health and within the Wisconsin Oncology Network (WON).
The PMMTB provides a forum for expert clinicians, pathologists and scientists to discuss and analyze tumor genotypes and molecular abnormalities in order to recommend patient specific targeted therapies.
The PMMTB is intended to supplement oncology tumor boards and includes a broad range of expert panel members.
Precision Medicine Molecular Tumor Board Presentation
Dustin Deming, Co-Director
Kayla K. Lemmon, Coordinator
Ben Parsons, Gundersen Lutheran Site Director
Timothy Goggins, Fox Valley Hematology and Oncology Site Director
Matthias Weiss, ThedaCare Cancer Care Site Director
Michael Thompson, Aurora Site Director
Ruth Warren, Green Bay Oncology Site Director